COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DISORDERS

    公开(公告)号:CA2644613A1

    公开(公告)日:2007-09-13

    申请号:CA2644613

    申请日:2007-03-07

    Applicant: ENDACEA INC

    Abstract: Methods and compositions for treating and preventing respiratory disorders are provided. The methods of the invention comprise administering to a subject a therapeutically effective amount of a pharmaceutically acceptable salt of an A 1 adenosine receptor antagonist, particularly 1-hydroxy-2-naphthoic acid salts or 3-hydroxy-2-naphthoic acid salts, more particularly a 1-hydroxy-2-naphthoic acid salt of 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-{2-[ethyl-(2-hydroxyethyl)amino]ethyl}-1-propyl-3,7-dihydropurine-2,6-dione (i.e., an L-97-1 xinafoic acid salt). Hydrates of the A 1 adenosine receptor antagonist salts described herein are further provided. The invention further encompasses pharmaceutical compositions comprising a pharmaceutically acceptable salt of an A 1 adenosine receptor antagonist in a pharmaceutically acceptable carrier. The compositions of the invention find use in methods for treating and preventing respiratory disorders.

    A1 ADENOSINE RECEPTOR ANTAGONISTS
    24.
    发明专利

    公开(公告)号:CA2528367A1

    公开(公告)日:2004-12-23

    申请号:CA2528367

    申请日:2004-06-07

    Applicant: ENDACEA INC

    Abstract: This invention relates to compounds of formula (I): wherein R1 is a branched or straight chain C1-C8 alkyl; R2 is of the formula (II), wherein n is an integer ranging from 1 to 8; R5 is H or (CH2)pCH3, and R6 is H or (CH2)mOH, wherein p is an integer ranging from 1 to 7 and m is an integer ranging from 1 to 8; R3 is of the formula (III), wherein q is an integer ranging from 1 to 8; and R7 is selected from the group consisting of H, OH, NH2, (CH2)tOH, and R9COOH; wherein R9 is a straight or branched chain alkylene or alkenylene group having 1 to 8 carbon atoms, and t is an integer ranging from 1 to 8; R 4 is of the formula (IV), wherein r is an integer ranging from 1 to 8 and R8 i s selected from the group consisting of H, OH, (CH2)fNH2, (CH2)sOH, and R10COO H; wherein f is 0 or f and s are independently integers ranging from 1 to 8; an d, R10 is a C1-C8 straight or branched chain alkylene or alkenylene; and; salts , solvates, and hydrates thereof. The present invention further provides metho ds of preparing the compounds of formula (I) and their use as therapeutic agent s and diagnostic agents.

    METHODS OF USE AND KIT FOR MEASUREMENT OF LIPOPOLYSACCHARIDE WITH A TIME RESOLVED FLUORESCENCE BASED ASSAY
    28.
    发明申请
    METHODS OF USE AND KIT FOR MEASUREMENT OF LIPOPOLYSACCHARIDE WITH A TIME RESOLVED FLUORESCENCE BASED ASSAY 审中-公开
    用时间分辨荧光测定法测定脂多糖的使用方法和试剂盒

    公开(公告)号:WO2012037361A3

    公开(公告)日:2012-05-18

    申请号:PCT/US2011051779

    申请日:2011-09-15

    CPC classification number: G01N33/92 G01N33/56911 G01N33/582 G01N33/68

    Abstract: The present invention relates to the methods of use for measurement of lipopolysaccharide (LPS) and methods of use for diagnosis of sepsis and LPS-related conditions. Specifically the present invention relates to a time resolved fluorescence (TRF) based assay for the measurement of LPS and methods of use for the measurement of LPS to diagnose sepsis, Gram-negative bacterial infections, and LPS-related conditions.

    Abstract translation: 本发明涉及用于测量脂多糖(LPS)的方法和用于诊断败血症和LPS相关病症的方法。 具体而言,本发明涉及用于测量LPS的基于时间分辨荧光(TRF)的测定法和用于测量LPS以诊断脓毒症,革兰氏阴性细菌感染和LPS相关病症的方法。

    A1 ADENOSINE RECEPTOR ANTAGONISTS
    30.
    发明申请

    公开(公告)号:WO2009086077A3

    公开(公告)日:2009-07-09

    申请号:PCT/US2008/087638

    申请日:2008-12-19

    Applicant: ENDACEA, INC.

    Abstract: This invention relates to compounds of formula (I), Wherein R 1 - R 4 are defined in the Specification, their uses in the practice of medicine, their medicinal formulations, their use in medical diagnosis, and their preparation.

Patent Agency Ranking